标普生物科技LOF(161127)利润分配表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 收入 |
67,404,368.76 |
129,328,104.47 |
-23,008,527.05 |
10,021,686.71 |
| 利息合计 |
71,759.49 |
124,411.76 |
30,542.78 |
85,921.63 |
| 其中:存款利息收入 |
71,759.49 |
124,411.76 |
30,542.78 |
85,921.63 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
77,291,108.38 |
59,333,560.24 |
-243,521.67 |
28,783,168.22 |
| 其中:股票投资收益 |
77,116,717.23 |
58,632,304.29 |
-582,981.22 |
28,254,159.75 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
- |
- |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
174,391.15 |
701,255.95 |
339,459.55 |
529,008.47 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-8,252,071.39 |
70,667,089.46 |
-22,285,370.07 |
-19,161,540.87 |
| 其他收入 |
366,629.50 |
102,023.74 |
5,459.86 |
31,700.12 |
| 费用 |
2,011,798.11 |
4,059,101.01 |
1,693,042.31 |
3,735,072.37 |
| 管理人报酬 |
1,497,634.73 |
3,009,907.55 |
1,230,636.11 |
2,536,979.91 |
| 基金托管费 |
374,408.72 |
763,383.77 |
318,565.91 |
792,806.20 |
| 销售服务费 |
60,411.50 |
71,370.54 |
10,057.98 |
10,024.35 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
79,343.16 |
214,439.15 |
133,782.31 |
395,261.91 |
| 利润总额 |
65,392,570.65 |
125,269,003.46 |
-24,701,569.36 |
6,286,614.34 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年